BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36222615)

  • 21. Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer.
    Scollo C; Baudin E; Travagli JP; Caillou B; Bellon N; Leboulleux S; Schlumberger M
    J Clin Endocrinol Metab; 2003 May; 88(5):2070-5. PubMed ID: 12727956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cure and survival of sporadic medullary thyroid carcinoma following systematic preoperative calcitonin screening.
    Torresan F; Mian C; Cavedon E; Iacobone M
    Langenbecks Arch Surg; 2019 Jun; 404(4):411-419. PubMed ID: 30903267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postoperative biochemical remission of serum calcitonin is the best predictive factor for recurrence-free survival of medullary thyroid cancer: a large-scale retrospective analysis over 30 years.
    Jung KY; Kim SM; Yoo WS; Kim BW; Lee YS; Kim KW; Lee KE; Jeong JJ; Nam KH; Lee SH; Hah JH; Chung WY; Yi KH; Park DJ; Youn YK; Sung MW; Cho BY; Park CS; Park YJ; Chang HS
    Clin Endocrinol (Oxf); 2016 Apr; 84(4):587-97. PubMed ID: 26175307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B.
    Skinner MA; DeBenedetti MK; Moley JF; Norton JA; Wells SA
    J Pediatr Surg; 1996 Jan; 31(1):177-81; discussion 181-2. PubMed ID: 8632274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Micromedullary thyroid cancer: how micro is truly micro?
    Pillarisetty VG; Katz SC; Ghossein RA; Tuttle RM; Shaha AR
    Ann Surg Oncol; 2009 Oct; 16(10):2875-81. PubMed ID: 19568813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative Clinical and Sonographic Predictors for Lateral Cervical Lymph Node Metastases in Sporadic Medullary Thyroid Carcinoma.
    Oh HS; Kwon H; Song E; Jeon MJ; Song DE; Kim TY; Lee JH; Hong SJ; Kim WB; Shong YK; Baek JH; Kim WG
    Thyroid; 2018 Mar; 28(3):362-368. PubMed ID: 29350102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is Encapsulated Medullary Thyroid Carcinoma Associated With a Better Prognosis? A Case Series and a Review of the Literature.
    Contarino A; Dolci A; Maggioni M; Porta FM; Lopez G; Verga U; Elli FM; Iofrida EF; Cantoni G; Mantovani G; Arosio M
    Front Endocrinol (Lausanne); 2022; 13():866572. PubMed ID: 35574005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sporadic medullary microcarcinoma of the thyroid: a retrospective analysis of eighty cases.
    Beressi N; Campos JM; Beressi JP; Franc B; Niccoli-Sire P; Conte-Devolx B; Murat A; Caron P; Baldet L; Kraimps JL; Cohen R; Bigorgne JC; Chabre O; Lecomte P; Modigliani E
    Thyroid; 1998 Nov; 8(11):1039-44. PubMed ID: 9848720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinico-pathologic and dynamic prognostic factors in sporadic and familial medullary thyroid carcinoma: an Israeli multi-center study.
    Twito O; Grozinsky-Glasberg S; Levy S; Bachar G; Gross DJ; Benbassat C; Rozental A; Hirsch D
    Eur J Endocrinol; 2019 Jul; 181(1):13-21. PubMed ID: 31048559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor Grade Predicts for Calcitonin Doubling Times and Disease-Specific Outcomes After Resection of Medullary Thyroid Carcinoma.
    Nigam A; Xu B; Spanheimer PM; Ganly I; Tuttle RM; Wong RJ; Shaha AR; Ghossein RA; Untch BR
    Thyroid; 2022 Oct; 32(10):1193-1200. PubMed ID: 35950622
    [No Abstract]   [Full Text] [Related]  

  • 31. Extension of Prophylactic Surgery in Medullary Thyroid Carcinoma. Differences Between Sporadic and Hereditary Tumours According to Calcitonin Levels and Lymph Node Involvement.
    Juez LD; Mercader E; Amunategui I; Febrero B; Rodríguez JM; Gómez-Ramírez J;
    World J Surg; 2022 Apr; 46(4):820-828. PubMed ID: 35089388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early postoperative calcitonin-to-preoperative calcitonin ratio as a predictive marker for structural recurrence in sporadic medullary thyroid cancer: A retrospective study.
    Jiao Z; Wu T; Jiang M; Jiang S; Jiang K; Peng J; Luo G; Yu Y; Chen W; Yang A
    Front Endocrinol (Lausanne); 2022; 13():1094242. PubMed ID: 36589824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medullary Thyroid Carcinoma: Survival Analysis and Evaluation of Mutation-Specific Immunohistochemistry in Detection of Sporadic Disease.
    Jayakody S; Reagh J; Bullock M; Aniss A; Clifton-Bligh R; Learoyd D; Robinson B; Delbridge L; Sidhu S; Gill AJ; Sywak M
    World J Surg; 2018 May; 42(5):1432-1439. PubMed ID: 29484475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamic risk stratification for medullary thyroid cancer according to the response to initial therapy.
    Kwon H; Kim WG; Jeon MJ; Song DE; Lee YM; Sung TY; Chung KW; Yoon JH; Hong SJ; Baek JH; Lee JH; Kim TY; Kim WB; Shong YK
    Endocrine; 2016 Jul; 53(1):174-81. PubMed ID: 26754662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medullary Thyroid Carcinoma: Prognostic Variables And Tumour Markers Affecting Survival.
    Hassan A; Siddique M; Riaz S; Khan AI; Nawaz MK; Bashir H
    J Ayub Med Coll Abbottabad; 2018; 30(Suppl 1)(4):S627-S632. PubMed ID: 30838820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-Term Outcome After Surgery for Medullary Thyroid Carcinoma: A Single-Center Experience.
    Torresan F; Cavedon E; Mian C; Iacobone M
    World J Surg; 2018 Feb; 42(2):367-375. PubMed ID: 29134313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-Term Follow-up in Medullary Thyroid Carcinoma.
    Raue F; Frank-Raue K
    Recent Results Cancer Res; 2015; 204():207-25. PubMed ID: 26494391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CALCITONIN SECRETORY INDEX AND UNSUSPECTED NODAL DISEASE IN MEDULLARY THYROID CARCINOMA.
    Filimon S; Payne RJ; Black MJ; Hier MP; Mlynarek AM; Forest VI; Tamilia M
    Endocr Pract; 2018 May; 24(5):460-467. PubMed ID: 29847167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determinative factors of biochemical cure after primary and reoperative surgery for sporadic medullary thyroid carcinoma.
    Gimm O; Ukkat J; Dralle H
    World J Surg; 1998 Jun; 22(6):562-7; discussion 567-8. PubMed ID: 9597929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk Factors Associated With Reoperation and Disease-Specific Mortality in Patients With Medullary Thyroid Carcinoma.
    Kuo EJ; Sho S; Li N; Zanocco KA; Yeh MW; Livhits MJ
    JAMA Surg; 2018 Jan; 153(1):52-59. PubMed ID: 28973144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.